Michael Holder

Michael B. Holder currently works at MDxHealth SA, as Independent Director from 2025, Cytek Biosciences, Inc., as Director from 2024, and Keyron Ltd., as Director from 2022.
Mr. Holder also formerly worked at Sensable Health, as Chief Executive Officer, Novation Holdings, Inc., as Chairman, President & Chief Executive Officer in 2011, Organ Transport Systems, Inc., as Chairman, Chief Executive & Financial Officer from 2010 to 2017, Alternative Energy Partners, Inc., as Director, Limitless LLC, as Director from 2018 to 2019, Cyphre Security Solutions LLC, as Director from 2016 to 2017, AMR Corp., as Principal, Premier Healthcare Solutions, Inc., as Principal, BeaconEye, Inc., as Chief Financial Officer, Heartland Capital Partners LLC, as Vice President, AVITA Medical, Inc., as Chief Financial Officer from 2021 to 2023, Immunecyte, Inc., as Chief Financial Officer from 2020 to 2021, and Clarkston Consulting, Inc., as Chief Financial Officer from 1998 to 2000.
Mr. Holder received his undergraduate degree from Kenan-Flagler Business School and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.